Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 8,220 shares at $39.77 ($327K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($327k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.77 | 7,344 | $292K | 89.2% |
| 2 | $40.34 | 876 | $35K | 10.8% |
| Total | $39.83 avg | 8,220 | $327K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |